Live Quote · NASDAQTVTXHealthcare· Biotechnology

Travere Therapeutics, Inc.

$47.00▼ 2.69%($-1.30)
MKT CAP $4.51BNEXT EARNINGS Feb 18, 2027
50%
Bullish
TickerSpark Score
54/100
▌ Mixed
50
Valuation
40
Profitability
100
Growth
48
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TVTX research report →

Analyst Price Target
$76.00+61.7% vs. today

Range $67 – $89

Analyst RatingBuy
15 Buy3 Hold0 Sell

Price Chart

+36.33% · this period
$67.52$47.16$26.79Nov 19May 22Nov 19
52-Week Range53% of range
Low
$22.59
Current
$47.00
High
$68.73